Publicis Health announced the launch of Insagic, a new insights and advisory business that combines data, design, and dialogues to deliver the activatable insights and transformational intelligence that healthcare marketers need to succeed and grow in platform world.
The Insagic Platform is built on an activatable, real-world data foundation, purpose-built for healthcare and the new outcomes economy. Its proprietary data architecture uniquely crosswalks billions of clinical and lifestyle data points, including the largest consumer database from Epsilon and more than 1.6 million minutes of exclusive, real-world doctor-patient dialogues.
“We believe human-centered, context-sensing, hyper-individualized patient support models—built in collaboration with stakeholders throughout the industry, sourcing data from across the healthcare ecosystem—will transform the larger healthcare industry as we know it. And Insagic is the indispensable partner that healthcare marketers need to make this transformation,” said Larry Mickelberg, Chief Commercial Officer, Publicis Health.
At launch, Insagic’s service offerings include: patient and HCP analytics; audience finding and segmentation; advanced targeting; persuasion modeling; intervention design; and outcomes optimization. Key product offerings are Verilogue DialogueStudies, HealthStyles, and SmartStudio.
“We know that diverse minds coming together to tackle complex healthcare and business challenges will always yield better results and better patient outcomes,” said Susan Manber, Chief Patient Officer, Publicis Health. “By bringing together an array of experts—from world-class linguists to leading data scientists—we can help health and wellness brands purposefully realize the promise of true patient centricity.”
Insagic’s launch partners include several of the world’s largest pharmaceutical companies, leading retail pharmacies, and innovative diagnostic providers, helping them address a wide range of key business questions, including, among others:
- How can we get more people to participate in clinical trials?
- What are the different patient types and how hyper-personalized content can drive behavior change?
- What do we need to do to take action to serve the underserved?
- Can we predict HCPs that are most likely to try, adopt, and remain loyal – and design an engagement strategy to drive productivity?
- Can we predict patients at the highest risk of lapsing therapy and design programs to change behavior?
SOURCE: PR Newswire